-
Presenter Profile: Important Safety Information—Off-Target Effects of New Therapies for Diabetes
Liana K. Billings, MD, MMSc, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Friday, June 21, at 3:45 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profiles: ADA Education Recognition Program (ERP)—Diversifying Diabetes Self-Management Education and Support (DSMES) Delivery Models
Kyle G. Lavergne, DNP, APRN, FNP-BC, and Renā Thompson, RN, WTA, CDCES, preview a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Saturday, June 22, at 8:00 a.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profiles: Translating Type 1 Diabetes Risk Alleles to Therapy
Aaron Michels, MD, and Farooq Syed, PhD, preview a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Sunday, June 23, at 8:00 a.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profile: Systemic Medications for Diabetic Retinopathy—Protective and Risk Factors
Andrew J. Barkmeier, MD, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Friday, June 21, at 3:45 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profile: Taking a Closer Look—Subcellular Approaches to Islet Biology
Irina Kaverina, PhD, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Friday, June 21, at 3:45 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profile: International Consensus Statement and Movement to End Diabetes Stigma
Matthew Garza, BS, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Saturday, June 22, at 3:15 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profile: Multiple Faces of Therapeutic Inertia in Diabetes
Steven Edelman, MD, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Sunday, June 23, at 4:30 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profile: Towards Innovative and Equitable Care in Youth-Onset Type 2 Diabetes
Stephanie T. Chung, MBBS, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Monday, June 24, at 8:00 a.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
SURMOUNT-OSA investigators will unveil new findings in obesity-related OSA
Atul Malhotra, MD, will be among the researchers sharing phase 3 clinical trial data showing the potential of a dual gastric inhibitory polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) receptor agonist used in the treatment of type 2 diabetes as a potential therapy for obesity-related obstructive sleep apnea (OSA). SURMOUNT-OSA evaluated how tirzepatide injection affected the…
-
STEP-HFpEF trial results show benefit of GLP-1 receptor agonists for patients with heart failure and diabetes
“Obesity is not just a comorbidity in people with heart failure with preserved ejection fraction but is a target for treatment,” said cardiac surgeon Subodh Verma, MD, PhD, FRCSC, one of the experts who will discuss new data from the STEP-HFpEF and STEP-HFpEF-DM trials.